199P Suppression of mutant Kirsten-RAS (KRAS G12C) non-small cell lung cancer (NSCLC) resistance to KRAS G12C inhibitors by dual inhibition of hepatocyte growth factor receptor (MET) and V-ATPase

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2023-04, Vol.18 (4), p.S149
Main Authors: Rosell, R., Gómez-Vázquez, J.L., Lewintre, E. Jantus, Ito, M., Cao, P., Cai, X., Xing, B., Fariñas, S. Calabuig, Cardona, A.F., Rodríguez, J.K., Jordán, M. Marco, Valdunciel, C. Pedraz, Molina-Vila, M.A., Codony-Servat, J., Dantes, Z., Aguilar, A., Sullivan, I.G., Horno, I. Moya, Cirera, L., Gonzalez-Cao, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
DOI:10.1016/S1556-0864(23)00452-5